Fertility and Sterility
Volume 92, Issue 1 , Pages 328-343, July 2009

Melatonin and the ovary: physiological and pathophysiological implications

  • Hiroshi Tamura, M.D., Ph.D.

      Affiliations

    • Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
    • Department of Obstetrics and Gynecology, Yamaguchi University Graduate School of Medicine, Ube, Japan
  • ,
  • Yasuhiko Nakamura, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Yamaguchi Grand Medical Center, Hofu, Japan
  • ,
  • Ahmet Korkmaz, M.D.

      Affiliations

    • Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
  • ,
  • Lucien C. Manchester, Ph.D.

      Affiliations

    • Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
  • ,
  • Dun-Xian Tan, M.D., Ph.D.

      Affiliations

    • Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
  • ,
  • Norihiro Sugino, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Yamaguchi University Graduate School of Medicine, Ube, Japan
  • ,
  • Russel J. Reiter, Ph.D.

      Affiliations

    • Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
    • Corresponding Author InformationReprint requests: Russel J. Reiter, Ph.D., Department of Cellular and Structural Biology, The University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900 (FAX: 210-567-6948).

Received 1 February 2008; received in revised form 2 May 2008; accepted 5 May 2008. published online 18 September 2008.

Objective

To summarize the role of melatonin in the physiology and pathophysiology of the ovary.

Design

Review of literature.

Setting

University Health Science Center.

Result(s)

Melatonin plays an essential role in the pathogenesis of many reproductive processes. Human preovulatory follicular fluid (FF) contains higher concentrations of melatonin than does plasma, and melatonin receptors are present in ovarian granulosa cells (GC). Melatonin has been shown to have direct effects on ovarian function. Reactive oxygen species and apoptosis are involved in a number of reproductive events including folliculogenesis, follicular atresia, ovulation, oocyte maturation, and corpus luteum (CL) formation. Melatonin and its metabolites are powerful antioxidants; the primitive and primary function of melatonin may be its actions as a receptor-independent free radical scavenger and a broad-spectrum antioxidant. A large amount of scientific evidence supports a local role of melatonin in the human reproductive processes. The indole also has potential roles in the pathophysiology of endometriosis, polycystic ovary syndrome (PCOS), and premature ovarian failure (POF).

Conclusion(s)

We summarize the current understanding of melatonin's essential functions in the human ovary. Melatonin could become an important medication for improving ovarian function and oocyte quality, and open new opportunities for the management of several ovarian diseases.

Key Words: Melatonin, follicular development, ovulation, oocyte quality, luteal function, PCOS, endometriosis, POF

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 H.T. has nothing to disclose. Y.N. has nothing to disclose. A.K. has nothing to disclose. L.C.M. has nothing to disclose. D.-X.T. has nothing to disclose. N.S. has nothing to disclose. R.J.R. has nothing to disclose.

PII: S0015-0282(08)01130-8

doi:10.1016/j.fertnstert.2008.05.016

Fertility and Sterility
Volume 92, Issue 1 , Pages 328-343, July 2009